Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTo get Mounjaro for weight loss in the UK, you need a prescription from a qualified prescriber who has assessed your clinical suitability — there is no other legal route. Mounjaro (tirzepatide) is a prescription-only medicine, so the process starts with a consultation, not a checkout. If you meet the eligibility criteria, a GPhC-registered Independent Prescriber reviews your case the same day and, if approved, your treatment can be dispatched that afternoon. This page sets out exactly how that works, who qualifies, and what to expect.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people arrive at this question having already seen Mounjaro advertised, offered with a quick online form, or even listed on social-media marketplaces. The impression that lingers is that it is more or less purchasable. It is not. Mounjaro is a Prescription-Only Medicine under UK law, which means a registered prescriber must assess you individually before any supply is lawful. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online (some fake products have contained insulin, causing serious harm) and enforcement action in 2025 saw roughly 20 million doses of illegally traded medicines (approximately £45 million in value) seized. A seller offering these medicines without a prior clinical assessment is either operating outside the law or selling something that is not what the label claims. The Mounjaro overview page has more on how the medicine works and why the assessment matters clinically, not just legally.
The legitimate route is straightforward once you know it: consultation with a registered prescriber, clinical review, prescription if suitable, supply from a GPhC-registered pharmacy. That is the sequence, every time, for every patient.
The licensed eligibility criteria for private prescription are set by Mounjaro's UK Summary of Product Characteristics. Adults with a BMI of 30 kg/m² or above qualify on BMI alone. Adults with a BMI between 27 and 29.9 kg/m² qualify if they have at least one weight-related condition, for example, high blood pressure, type 2 diabetes, prediabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds can apply for certain ethnic backgrounds under UK clinical guidance. The full eligibility criteria page covers this in detail, including how comorbidities are assessed. BMI alone, though, never guarantees a prescription; the prescriber considers the whole picture, including current medicines and contraindications. If you want a quick sense of where your numbers sit, the Mounjaro BMI calculator gives you a starting point before your consultation. Mounjaro is not licensed for use in pregnancy, breastfeeding, or for those actively trying to conceive, and it is not for people under 18.
For NHS access, the criteria are considerably stricter. The NHS and private access routes page explains the phased rollout (currently limited to people with a BMI of 40 or above and four or more qualifying conditions) and how GP prescribing under the new contract is rolling out unevenly across practices and regions. Most people asking this question today will not yet meet the NHS threshold, which is why private prescription through a regulated pharmacy is the realistic path for the majority.
If you go the private route, here is what a properly run consultation process looks like. You complete a structured medical questionnaire covering your weight, health history, current medicines and relevant conditions. A GPhC-registered Independent Prescriber (a real clinician, not a triage algorithm) reads your responses and either approves your prescription, requests more information, or declines if it is not clinically appropriate. At nume, this review happens the same day. Before any prescription is issued, identity is verified by photo ID and weight is confirmed on a live video call; this is not optional or skippable. If you are transferring from another provider or requesting a dose increase, clinical evidence of your current treatment is required.
Once approved and the prescription is issued, your treatment is dispatched from our GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register) and delivered free by DPD the next working day in plain, unbranded packaging. Orders placed before 12pm Monday to Friday go out the same day once clinically approved. There are no subscriptions and no auto-renewals; every repeat order is reviewed again before it goes out. If you want to understand more about what affects the cost of private treatment, the Eli Lilly price increase page sets out the market context honestly.
Mounjaro is a once-weekly subcutaneous injection, administered via a pre-filled KwikPen. Each pen contains four weekly doses. The starting dose, 2.5 mg, exists to let your system adjust, the first four weeks are about tolerability, and your prescriber will guide titration from there based on how you respond. Some patients also ask whether taking Mounjaro every other week is a viable approach for weight loss, and that page covers the clinical thinking behind dosing frequency in full. The most common side effects are gastrointestinal: nausea, loose stools, constipation, reflux and fatigue are all reported, particularly around dose changes, and typically ease within a week or two. NICE's appraisal of tirzepatide (TA1026) and the NHS tirzepatide medicines page are the two most useful official references for understanding what is expected at each stage. If you have questions during treatment (about a missed dose, a side effect, or whether to continue) our prescribers and aftercare team are available seven days a week. You can also find answers to common queries on the FAQs page.
If you have read this far and think you may be eligible, the next step is a consultation. It is free, takes a few minutes, and a prescriber will have reviewed it before the end of the day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.